For instance, Sénant et al. demonstrated that multiplex testing for aCL, anti-β2GPI and factor II enhances diagnostic performance in primary APS, resulting in a 15% increase in sensitivity compared with traditional ELISA. This evidence concerns the gene APOH and autoimmune polyendocrinopathy.